DE10075025I2 - Produkt f}r die kontrollierte Ern{hrung mit Triglyceriden f}r hyperkatabolische S{ugetiere. - Google Patents

Produkt f}r die kontrollierte Ern{hrung mit Triglyceriden f}r hyperkatabolische S{ugetiere.

Info

Publication number
DE10075025I2
DE10075025I2 DE2000175025 DE10075025C DE10075025I2 DE 10075025 I2 DE10075025 I2 DE 10075025I2 DE 2000175025 DE2000175025 DE 2000175025 DE 10075025 C DE10075025 C DE 10075025C DE 10075025 I2 DE10075025 I2 DE 10075025I2
Authority
DE
Germany
Prior art keywords
mammal
fatty acids
chain fatty
triglycerides
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE2000175025
Other languages
English (en)
Other versions
DE10075025I1 (de
Inventor
Georg L Blackburn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi AB
Original Assignee
Fresenius Kabi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi AB filed Critical Fresenius Kabi AB
Application granted granted Critical
Publication of DE10075025I1 publication Critical patent/DE10075025I1/de
Publication of DE10075025I2 publication Critical patent/DE10075025I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE2000175025 1983-01-26 1984-01-16 Produkt f}r die kontrollierte Ern{hrung mit Triglyceriden f}r hyperkatabolische S{ugetiere. Active DE10075025I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/461,077 US4528197A (en) 1983-01-26 1983-01-26 Controlled triglyceride nutrition for hypercatabolic mammals

Publications (2)

Publication Number Publication Date
DE10075025I1 DE10075025I1 (de) 2000-11-09
DE10075025I2 true DE10075025I2 (de) 2006-02-02

Family

ID=23831126

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8484100376T Expired DE3462389D1 (en) 1983-01-26 1984-01-16 Product for controlled triglyceride nutrition of hypercatabolic mammals
DE2000175025 Active DE10075025I2 (de) 1983-01-26 1984-01-16 Produkt f}r die kontrollierte Ern{hrung mit Triglyceriden f}r hyperkatabolische S{ugetiere.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8484100376T Expired DE3462389D1 (en) 1983-01-26 1984-01-16 Product for controlled triglyceride nutrition of hypercatabolic mammals

Country Status (11)

Country Link
US (1) US4528197A (de)
EP (1) EP0121036B1 (de)
JP (1) JPH0611708B2 (de)
AT (1) ATE25492T1 (de)
AU (1) AU574659B2 (de)
CA (1) CA1216188A (de)
CY (1) CY1484A (de)
DE (2) DE3462389D1 (de)
HK (1) HK102589A (de)
NL (1) NL990017I2 (de)
SG (1) SG24189G (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4678807A (en) * 1984-03-01 1987-07-07 Baxter Travenol Laboratories, Inc. Method for directed visceral metabolism of medium chain triglycerides
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US4847296A (en) * 1984-09-13 1989-07-11 Babayan Vigen K Triglyceride preparations for the prevention of catabolism
US4690820A (en) * 1985-06-07 1987-09-01 The State University Of New York High-caloric, high-fat dietary formula
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
DE3641265A1 (de) * 1986-12-03 1988-06-09 Walter Dr Mach Schweineserum mit erhoehtem gehalt an organspezifischen peptiden, seine herstellung und verwendung
US4810726A (en) * 1987-04-01 1989-03-07 New England Deaconess Hospital Corporation Kernel oils and disease treatment
US4832975A (en) * 1987-09-29 1989-05-23 The Procter & Gamble Company Tailored triglycerides having improved autoignition characteristics
US5288512A (en) * 1987-12-15 1994-02-22 The Procter & Gamble Company Reduced calorie fats made from triglycerides containing medium and long chain fatty acids
US4906664A (en) * 1988-01-15 1990-03-06 New England Deaconess Hospital Corporation Nutritional supplement for treatment of cancer cachexia
US5081105A (en) * 1988-01-15 1992-01-14 New England Deaconess Hospital Corporation Method of treating cancer using structured lipids
US4952606A (en) * 1988-04-05 1990-08-28 New England Deaconess Hospital Corporation Structured lipid containing dairy fat
US4863753A (en) * 1988-06-30 1989-09-05 The Procter & Gamble Company Reduced calorie peanut butter
CA2012381C (en) * 1989-03-28 1997-07-01 Paul Seiden Reduced calorie fat compositions containing polyol polyesters and reduced calorie triglycerides
ES2069073T3 (es) * 1989-04-07 1995-05-01 New England Deaconess Hospital Trigliceridos de cadena corta.
IT1232161B (it) * 1989-07-31 1992-01-25 Sigma Tau Ind Farmaceuti Uso dell'acido sebacico e di suoi derivati nell'alimentazione enterale e parentaerale e composizioni farmaceutiche contenenti tali composti
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
WO1992019237A1 (en) * 1991-05-08 1992-11-12 Novo Nordisk A/S Use of a lipid for production of a pharmaceutical enteral preparation for treatment of lipid malabsorption
US5260336A (en) * 1992-04-30 1993-11-09 New England Deaconess Hospital Corporation Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
CN1087522A (zh) 1992-09-14 1994-06-08 韦斯塔药品有限公司 用于治疗和预防婴儿代谢紊乱的组合物
US5571553A (en) * 1992-09-18 1996-11-05 University Of Medicine And Dentistry Of New Jersey High energy food products containing partially hydrogenated structured lipids
JP3068970B2 (ja) * 1992-11-30 2000-07-24 中部飼料株式会社 子畜用液状飼料組成物
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5329502A (en) * 1993-12-10 1994-07-12 Haring Chad T Light bending watch apparatus
US5821217A (en) * 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
US5885594A (en) * 1997-03-27 1999-03-23 The Procter & Gamble Company Oral compositions having enhanced mouth-feel
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
AU763464B2 (en) 1999-03-08 2003-07-24 Medicure Inc. Pyridoxal analogues for vitamin B-6 disorders
CA2376029A1 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
CA2383252A1 (en) 1999-08-24 2001-03-01 Medicure International Inc. Treatment of cardiovascular related pathologies
KR20020060199A (ko) * 1999-10-19 2002-07-16 후지야마 아키라 동물의 비육 촉진제 및 비육 촉진 방법
JP2003525303A (ja) 2000-02-29 2003-08-26 メディキュア インターナショナル インコーポレイテッド 心臓保護ホスホン酸塩およびマロン酸塩
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US20070179197A1 (en) * 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
DE60138019D1 (de) 2000-05-01 2009-04-30 Accera Inc Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
WO2002004421A2 (en) 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
SK12772003A3 (sk) * 2001-04-18 2004-07-07 Prometic Biosciences Inc. Stredne dlhé mastné kyseliny, glyceridy a analógy ako faktory prežitia a aktivácie neutrofilov
KR20020081632A (ko) * 2001-04-19 2002-10-30 (주)라이브맥스 Ｃｌａ가 함유된 재구성 지질의 제조방법 및 이용방법
US8142799B2 (en) * 2001-12-18 2012-03-27 Tamea Rae Sisco High potency clinical anti-craving treatment and method of use
US8142800B1 (en) * 2001-12-18 2012-03-27 Tamea Rae Sisco Oral high potency clinical anti-craving treatment and method of use
US20060189545A1 (en) * 2003-03-06 2006-08-24 Henderson Samuel T Novel chemical entities and methods for their use in treatment of metabolic disorders
AU2005304220A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060252775A1 (en) * 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
WO2007001883A2 (en) * 2005-06-20 2007-01-04 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
US20070218183A1 (en) * 2006-03-14 2007-09-20 Bunge Oils, Inc. Oil composition of conjugated linoleic acid
EP2001293B9 (de) * 2006-04-03 2019-04-17 Accera, Inc. Verwendung ketogener verbindungen zur behandlung altersbedingter gedächtnisschwächen
EP2650381B1 (de) 2007-07-31 2016-09-21 Accera, Inc. Verwendung genomischer und ketogener Verbindungen zur Behandlung von beeinträchtigten kognitiven Funktionen
CN102105071A (zh) * 2008-07-03 2011-06-22 艾克塞拉公司 用于治疗神经性障碍的乙酰乙酸的单甘油酯及其衍生物
US8105809B2 (en) * 2008-07-03 2012-01-31 Accera, Inc. Enzymatic synthesis of acetoacetate esters and derivatives
CN102319212B (zh) * 2011-09-01 2013-08-21 辽宁中海康生物药业有限公司 一种丁酸氯维地平结构脂肪乳及其制备方法
CN113406247B (zh) * 2021-03-31 2023-04-07 广州海关技术中心 一种基于irms、lc-q-tof-ms和多元素分析相结合的大豆产地溯源识别方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4330557A (en) * 1979-05-21 1982-05-18 Claudio Cavazza Acyl-carnitine and use thereof in parenteral administration of triglycerides
JPS57110176A (en) * 1980-12-27 1982-07-08 Snow Brand Milk Prod Co Ltd Nutrious food composition for tube feeding
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet

Also Published As

Publication number Publication date
NL990017I1 (nl) 1999-08-02
JPH0611708B2 (ja) 1994-02-16
EP0121036A1 (de) 1984-10-10
NL990017I2 (nl) 2000-07-03
CA1216188A (en) 1987-01-06
EP0121036B1 (de) 1987-02-25
DE10075025I1 (de) 2000-11-09
JPS59141522A (ja) 1984-08-14
HK102589A (en) 1990-01-05
AU574659B2 (en) 1988-07-14
DE3462389D1 (en) 1987-04-02
SG24189G (en) 1989-07-14
CY1484A (en) 1989-12-08
US4528197A (en) 1985-07-09
ATE25492T1 (de) 1987-03-15
AU2378484A (en) 1984-08-02

Similar Documents

Publication Publication Date Title
DE10075025I2 (de) Produkt f}r die kontrollierte Ern{hrung mit Triglyceriden f}r hyperkatabolische S{ugetiere.
TR199700537A2 (xx) Diyete uygun dengelenmi� s�t �r�n�.
ATE167983T1 (de) Phospholipidhaltige fettmischung mit lcp- fettsäuren
MX9201879A (es) Substitutos de la grasa, derivados del suero de laleche, procedimiento para su preparacion y productos que los contienen.
CY1109004T1 (el) Στοιχειακο εντερικο θρεπτικο προϊον που περιεχει υδρολυμενη πρωτεϊνη σογιας και μερικως υδρολυμενο καzεϊνικο
ES453476A1 (es) Procedimiento para proporcionar una fuente de proteinas en forma concentrada.
AR001383A1 (es) Producto nutricional que comprende grasa, carbohidrato y protina, util para dismnuir los niveles de colesterol en suero en humanos.
PA8434401A1 (es) Producto alimenticio congelado.
AU2795295A (en) Novel dietetic phospholipid compositions and use thereof as a dietary supplement
CA2147302A1 (en) A lipid composition for normalizing injury
DE68924429D1 (de) Diät zur besserem Ueberleben von Kranken mit Sepsis.
EP0775449A4 (de) Hühnereier mit einem hohen anteil an mehrfach ungesättigten fettsäuren, verfahren für deren herstellung und die verwendung derselben
ES551348A0 (es) Un procedimiento para la preparacion de una formula hipoalergenica alimenticia enteral mejorada.
DE3785667D1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DE69327047D1 (de) Nahrungsmittel für Menschen während Strahlen- und/oder Chemotherapie
DE3470277D1 (en) Dietetic composition
ATE114462T1 (de) Strukturiertes lipid enthaltend milchfett.
ES2065169T3 (es) Metodo para la produccion de un hidrolizado de proteina vegetal.
ZA851046B (en) Method for directed visceral metabolism of medium chain triglycerides
AU1489688A (en) Omega-3 fatty acids in traumatic injury treatment
ATE209487T1 (de) Verfahren zur behandlung von krebs mittels strukturierten lipiden
DE3877723D1 (de) Diaetoel.
ES2164876T3 (es) Procedimiento para la fabricacion de alimentos dieteticos para lactantes y niños prematuros y alimentos dieteticos.
Cho et al. Changes of corn proteins and lipids induced by thermal processing
GR1002989B (el) Μεθοδος παρασκευης μειγματος ζοωτροφων για την παραγωγη αυγων ωμεγα ή ω-3 αυγων